Hometop nav spacerAbout ARStop nav spacerHelptop nav spacerContact Ustop nav spacerEn Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
United States Department of Agriculture Agricultural Research Service
Search
 
 
 
National Programs
International Programs
Find Research Projects
The Research Enterprise
Office of Scientific Quality Review
Research Initiatives
 

Title: IN VIVO EFFECT OF CPG OLIGODEOXYNUCLEOTIDE ON EIMERIA INFECTION IN CHICKENS.

Authors
item Dalloul, Rami - ARS USDA BELTSVILLE MD
item Lillehoj, Hyun
item Okamura, Masashi - ARS USDA BELTSVILLE MD
item Xie, Hang - U MD COLLEGE PARK MD
item Min, Wongi
item Ding, Xicheng - ARS USDA BELTSVILLE MD
item Heckert, Robert

Submitted to: Avian Diseases
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: July 7, 2004
Publication Date: September 7, 2004
Citation: Dalloul, R.A., Lillehoj, H.S., Okamura, M., Xie, H., Min, W., Ding, X., Heckert, R.A. 2004. In vivo effect of cpg oligodeoxynucleotide on Eimeria infection in chickens. Avian Diseases. 48:783-790.

Interpretive Summary: Poultry coccidiosis is the major parasitic disease of poultry and causes major economic losses to the poultry industry worldwide. Ability to control avian coccidiosis using a non-chemical method will have a major impact on US industry. In this study, ARS scientists discovered a new way to enhance host natural immunity against intestinal parasites using oligopeptide sequences. They showed that certain oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs (CpG ODNs) stimulate chicken immunity to kill intracellular parasites and enhance disease resistance against avian coccidiosis. This is the first report showing their use in poultry to protect against intracellular parasites. This finding will lay groundwork for the development of novel non-chemical control strategy against avian coccidiosis.

Technical Abstract: Poultry coccidiosis is the major parasitic disease of poultry and until now no recombinant vaccine has been developed; rather the poultry industry relies on prophylactic medication and live vaccines. Short oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs (CpG ODNs) have been shown to be effective immunoprotective agents and vaccine adjuvants in mammalian systems. Their use in poultry to protect against intracellular parasites has not been reported to date. The present work investigated the effects of CpG ODN treatment on host susceptibility to Eimeria infection in two chicken strains with different genetic background, SC and TK. The data show that CpG ODN enhanced the birds' resistance to coccidiosis in a normally susceptible chicken strain (TK), as shown by reduced oocyst shedding and improved weight gain. CpG treatment had a differential effect on body weight gains and serum antibody responses depending on the chicken strain and ODN dose, delivery route, and backbone. This study shows for the first time that CpG ODNs could be used as immunoprotective agents in Eimeria-infected chickens to boost resistance to the pathogen and improve performance. Future research is needed to optimize their use alone and as vaccine adjuvants leading to practical application in the poultry industry and reducing the economic impact of coccidiosis and other poultry diseases.

   
 
 
Last Modified: 05/19/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House